Faron, etusivu

releases and publications

Top-Line Data on Bexmarilimab Dose Variation

Regulatory

Faron to Host Bexmarilimab Update Webcast

Traumakine Data Presented at MHSR Symposium

Faron to Present at Upcoming Conferences

Faron Reports 2022 Half-Year Financial Results

Regulatory

Notice of Half-Year Financial Results

Regulatory

Results of EGM

Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Registration of New Shares

Regulatory

Announcement of Placing

Regulatory
PreviousNext
Back to top